##  [Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps](/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps-0 "Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps") 

  Dec 11, 2019